TAIZ -Monocytes for the Induction of Donor Specific Tolerance in Renal Allograft Recipients (Cadaver Kidney)

Phase 1

• Conditions: Renal Transplantation

• Registration Number: NCT00223093
• Lead Sponsor: University Hospital Schleswig-Holstein

Brief Summary

Induce tolerance or reduce the amount of immunosuppression after renal transplant patient (receiving cadaver kidney)with so called TAIZ-monocytes

Detailed Description

Not available

Study Timeline

• Status Verified: 2003-04
• Study Start: 2004-02
• Study Completion: 2005-08
• Study First Submitted: 2005-09-14
• Study First Submitted QC: 2005-09-14
• Study First Posted: 2005-09-22
• Last Update Submitted: 2005-10-27
• Last Update Posted: 2005-10-28

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
graft survival
replacement of immunosuppressives after treatment with Transplant-Acceptance Inducing Cells (TAIC)
serum creatinine
rejection episodes
re-introduction of immunosuppressives.

Secondary Outcome Measures

Name	Time	Method
safety and tolerability of the treatment with Transplant-Acceptance Inducing Cells (TAIC) Adverse Events (AEs)